SCHEMBL24208533

SCHEMBL24208533

C=Cc1cc2c(cc1/C=C\C)oc1ccc(-c3c4ccccc4c(-c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)c4ccccc34)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ HPGD P15428 3/20 0.35
▸ AHR P35869 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CHEK2 O96017 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ SENP7 Q9BQF6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23849346 0.94 PLA2G2A (0.37) MMP12MMP13HPGDAHRKDM4E
SCHEMBL21127448 0.94 PLA2G2A (0.37) MMP12MMP13HPGDAHRKDM4E
SCHEMBL23060310 0.94 PLA2G2A (0.37) MMP12MMP13HPGDAHRKDM4E
SCHEMBL23109594 0.93 PLA2G2A (0.35) MMP12MMP13KDM4EMEN1ALDH1A1
SCHEMBL21169833 0.93 PLA2G2A (0.36) MMP12MMP13KDM4EMEN1MAPT
SCHEMBL21923886 0.93 PLA2G2A (0.33) HPGDAHRKDM4EMEN1ALDH1A1
SCHEMBL23919645 0.93 PLA2G2A (0.33) HPGDAHRKDM4EMEN1ALDH1A1
SCHEMBL20416908 0.92 PLA2G2A (0.37) MMP12MMP13KDM4EMEN1MAPT
SCHEMBL23371064 0.91 CASP3 (0.31) CASP3SENP7SENP6
SCHEMBL21150166 0.90 PLA2G2A (0.33) MMP12MMP13PLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11618722-B2 Compound, composition, organic electroluminescent element, and electronic appliance IDEMITSU KOSAN CO., LTD. (JP) 2023-04-04 — — US disclosed
US-11342512-B2 Compounds for organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2022-05-24 — — US disclosed
US-20220020925-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11618722-B2 Compound, composition, organic electroluminescent element, and electronic appliance FGF23, SUZ12, RPL24 MMP12 1590/4885MMP13 1787/4885HPGD 3219/4885
US-11342512-B2 Compounds for organic electroluminescence device RPS19, RPL19, RPL18 MMP12 2239/4885MMP13 2258/4885HPGD 3357/4885
US-20220020925-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE RPS19, RPL18, RPL19 MMP12 1260/4885MMP13 1345/4885HPGD 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback